erythromelalgia
Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.
Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (<span class="disease" id="19549232-0-85-100">erythromelalgia</span>) identified to have a mutation in the <span class="gene" id="19549232-0-139-144">SCN9A</span> gene, encoding a voltage-gated sodium channel.